Fatigue, a common complaint in medical practice, is often a complex and multifaceted condition. It can be a symptom of numerous underlying conditions, making diagnosis and management a challenging task for physicians. This article aims to provide a comprehensive clinical approach to diagnosing and managing fatigue.
A detailed patient history and physical examination are the cornerstones of fatigue assessment. The duration, severity, onset, and any associated symptoms should be thoroughly investigated. Additionally, evaluating psychosocial factors and lifestyle habits can provide valuable insights into potential contributing factors. Relevant laboratory tests may be necessary to rule out conditions like anemia, thyroid disorders, or chronic infections.
Given the broad differential diagnosis for fatigue, a systematic approach is essential. This often involves ruling out common medical causes first, such as endocrine or hematologic disorders. If these are absent, the next step is to consider psychiatric disorders like depression or anxiety. If no clear cause is identified, the diagnosis of chronic fatigue syndrome (CFS) may be considered, using established criteria.
Treatment should be tailored to the underlying cause of fatigue. This may involve pharmacological interventions, lifestyle modifications, or psychological therapies. For patients diagnosed with CFS, cognitive behavioral therapy and graded exercise therapy have shown promising results. However, the management of fatigue often requires a multidisciplinary approach, involving physicians, psychologists, and physiotherapists.
Understanding and managing fatigue can be a complex process, due to its multifactorial nature and the wide range of potential underlying conditions. A systematic and comprehensive approach to its diagnosis and treatment is crucial. Further research is needed to enhance our understanding of fatigue and develop more effective management strategies.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation